Waalkes S - Search Results

1

Urinary collecting system invasion is no independent prognostic factor in renal cell carcinoma.

Waalkes S, Merseburger AS, Herrmann TR, Kramer MW, Wegener G, Rustemeier J, Hofmann R, Kuczyk MA, Schrader AJ. Waalkes S, et al. World J Urol. 2010 Jun;28(3):283-8. doi: 10.1007/s00345-010-0526-6. Epub 2010 Mar 18. World J Urol. 2010. PMID: 20237784

2

External validation of the preoperative anatomical classification for prediction of complications related to nephron-sparing surgery.

Waldert M, Waalkes S, Klatte T, Kuczyk MA, Weibl P, Schüller G, Merseburger AS, Remzi M. Waldert M, et al. Among authors: waalkes s. World J Urol. 2010 Aug;28(4):531-5. doi: 10.1007/s00345-010-0577-8. Epub 2010 Jul 7. World J Urol. 2010. PMID: 20607246

3

Present state of target therapy for disseminated renal cell carcinoma.

Waalkes S, Kramer M, Herrmann TR, Schrader AJ, Kuczyk MA, Merseburger AS. Waalkes S, et al. Immunotherapy. 2010 May;2(3):393-8. doi: 10.2217/imt.10.14. Immunotherapy. 2010. PMID: 20635903 Review.

4

Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancer.

Waalkes S, Merseburger AS, Kramer MW, Herrmann TR, Wegener G, Rustemeier J, Hofmann R, Schrader M, Kuczyk MA, Schrader AJ. Waalkes S, et al. Cancer Causes Control. 2010 Nov;21(11):1905-10. doi: 10.1007/s10552-010-9618-2. Epub 2010 Jul 22. Cancer Causes Control. 2010. PMID: 20652393

5

Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer.

Waalkes S, Atschekzei F, Kramer MW, Hennenlotter J, Vetter G, Becker JU, Stenzl A, Merseburger AS, Schrader AJ, Kuczyk MA, Serth J. Waalkes S, et al. BMC Cancer. 2010 Sep 22;10:503. doi: 10.1186/1471-2407-10-503. BMC Cancer. 2010. PMID: 20860816 Free PMC article.

6

Is there a need to further subclassify pT2 renal cell cancers as implemented by the revised 7th TNM version?

Waalkes S, Becker F, Schrader AJ, Janssen M, Wegener G, Merseburger AS, Schrader M, Hofmann R, Stöckle M, Kuczyk MA. Waalkes S, et al. Eur Urol. 2011 Feb;59(2):258-63. doi: 10.1016/j.eururo.2010.10.005. Epub 2010 Oct 15. Eur Urol. 2011. PMID: 21030143

7

Does male sex influence the prognosis of patients with renal cancer?

Waalkes S, Rott H, Herrmann TR, Wegener G, Kramer MW, Merseburger AS, Schrader M, Hofmann R, Kuczyk MA, Schrader AJ. Waalkes S, et al. Onkologie. 2011;34(1-2):24-8. doi: 10.1159/000323379. Epub 2011 Jan 24. Onkologie. 2011. PMID: 21346381

8

[Overweight is an advantageous prognostic marker in patients with clear cell kidney cancer].

Waalkes S, Eggers H, Rustemeier J, Wegener G, Jentzmik F, Schrader M, Hofmann R, Kuczyk MA, Schrader AJ; Für das deutsche Netzwerk Nierenzelltumoren. Waalkes S, et al. Urologe A. 2011 Sep;50(9):1118-24. doi: 10.1007/s00120-011-2628-1. Urologe A. 2011. PMID: 21720831 German.

9

[Current state of systemic therapy of metastatic renal cell carcinoma].

Merseburger AS, Waalkes S, Kuczyk MA. Merseburger AS, et al. Among authors: waalkes s. Urologe A. 2009 Sep;48(9):983-4, 986, 988-9. doi: 10.1007/s00120-009-2072-7. Urologe A. 2009. PMID: 19669118 Review. German.

10

Sorafenib reveals efficacy in sequential treatment of metastatic renal cell cancer.

Merseburger AS, Simon A, Waalkes S, Kuczyk MA. Merseburger AS, et al. Among authors: waalkes s. Expert Rev Anticancer Ther. 2009 Oct;9(10):1429-34. doi: 10.1586/era.09.96. Expert Rev Anticancer Ther. 2009. PMID: 19828003 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters